When Sydney makeup artist Michelle Dubé felt mildly nauseous, she assumed she'd eaten something bad. Just one week later, ...
This is an inside story. I would appreciate it if only those interested continue reading.🙇        The Story So ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
When contaminated instruments spread germs that resist antibiotics, the problem becomes more serious. Bacteria such as ...
A pair of lawmakers is pressing Health and Human Services Secretary Robert F. Kennedy Jr. to make liver cancer surveillance a ...
Intismeran plus KEYTRUDA significantly reduced the risk of recurrence or death by 42% (HR=0.58 [95% CI, 0.45–0.75]; two-sided p<0.001) compared to KEYTRUDA alone for patients with completely resected ...
Get Liver Transplant News on Telangana Today, Liver Transplant latest news, Liver Transplant news, | Telangana Today ...
KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...
For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...
For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...